Employer-Paid

Rep. Aaron Bean suggested at a House hearing that clear service price menus might help.

Regeneron will provide Otarmeni — a new gene therapy for an ultra-rare form of genetic hearing loss <a href="https://investor.regeneron.com/news-releases/news-release-details/otarmenitm-lunsotogene-parvec-cwha-approved-fda-first-and-only">recently approved</a> by the U.S. Food and Drug Administration — for free under a new agreement with the U.S. government.

In a fireside chat, Mia Hamm emphasizes that true greatness stems from a relentless commitment to learning, empowering others, and fostering a team-first culture built on consistent preparation and mutual appreciation.

The opening sessions of this year's BenefitsPRO Broker Expo in Chicago kicked off with one of the year's hottest topics: GLP-1 drugs.

Asking the right questions can help benefits professionals and employers find a PBM who is truly working as a partner to cut prescription drug costs.

Connecticut Insurance Department cited five major insurers — Aetna, Anthem, ConnectiCare, Cigna, and UnitedHealthcare — for failing to provide mental health and substance use coverage equal to their medical and surgical benefits.